Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy. por Gasser, O, Brander, C, Wolbers, M, Brown, N, Rauch, A, Günthard, H, Battegay, M, Hess, C

Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load. por Oxenius, A, Günthard, H, Hirschel, B, Fidler, S, Weber, J, Easterbrook, P, Bell, J, Phillips, R, Price, D

Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection. por Fitzmaurice, K, Hurst, J, Dring, M, Rauch, A, McLaren, P, Günthard, H, Gardiner, C, Klenerman, P

Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline por Baxter, J, Villabona-Arenas, J, Thompson, RN, Hue, S, Regoes, R, Kouyos, R, Gunthard, H, Albert, J, Brown, AL, Atkins, K

Precise identification of a human immunodeficiency virus type 1 antigen processing mutant. por Zimbwa, P, Milicic, A, Frater, J, Scriba, T, Willis, A, Goulder, P, Pillay, T, Gunthard, H, Weber, J, Zhang, H, Phillips, R

Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load. por Oxenius, A, Sewell, A, Dawson, S, Günthard, H, Fischer, M, Gillespie, G, Rowland-Jones, S, Fagard, C, Hirschel, B, Phillips, R, Price, D

Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. por Scherer, A, Frater, J, Oxenius, A, Agudelo, J, Price, D, Günthard, H, Barnardo, M, Perrin, L, Hirschel, B, Phillips, R, Mclean, A

HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts. por Gasser, O, Bihl, F, Wolbers, M, Loggi, E, Steffen, I, Hirsch, H, Günthard, H, Walker, B, Brander, C, Battegay, M, Hess, C

Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy. por Oxenius, A, Mclean, A, Fischer, M, Price, D, Dawson, S, Hafner, R, Schneider, C, Joller, H, Hirschel, B, Phillips, R, Weber, R, Günthard, H

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study. por Wolbers, M, Opravil, M, von Wyl, V, Hirschel, B, Furrer, H, Cavassini, M, Vernazza, P, Bernasconi, E, Battegay, M, Yerly, S, Günthard, H, Bucher, H

Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load. por Oxenius, A, Price, D, Dawson, S, Günthard, H, Fischer, M, Perrin, L, Ramirez, E, Fagard, C, Hirschel, B, Scullard, G, Weber, J, Mclean, A, Phillips, R

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. por Oxenius, A, Price, D, Günthard, H, Dawson, S, Fagard, C, Perrin, L, Fischer, M, Weber, R, Plana, M, García, F, Hirschel, B, McLean, A, Phillips, R

Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptio... por Joos, B, Trkola, A, Fischer, M, Kuster, H, Rusert, P, Leemann, C, Böni, J, Oxenius, A, Price, D, Phillips, R, Wong, J, Hirschel, B, Weber, R, Günthard, H

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. por Rohrbach, J, Robinson, N, Harcourt, G, Hammond, E, Gaudieri, S, Gorgievski, M, Telenti, A, Keiser, O, Günthard, H, Hirschel, B, Hoffmann, M, Bernasconi, E, Battegay, M, Furrer, H, Klenerman, P, Rauch, A

Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. por Frater, A, Brown, H, Oxenius, A, Günthard, H, Hirschel, B, Robinson, N, Leslie, A, Payne, R, Crawford, H, Prendergast, A, Brander, C, Kiepiela, P, Walker, B, Goulder, P, McLean, A, Phillips, R

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. por di Iulio, J, Ciuffi, A, Fitzmaurice, K, Kelleher, D, Rotger, M, Fellay, J, Martinez, R, Pulit, S, Furrer, H, Günthard, H, Battegay, M, Bernasconi, E, Schmid, P, Hirschel, B, Barnes, E, Klenerman, P, Telenti, A, Rauch, A

Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. por Gaudieri, S, Rauch, A, Pfafferott, K, Barnes, E, Cheng, W, McCaughan, G, Shackel, N, Jeffrey, G, Mollison, L, Baker, R, Furrer, H, Günthard, H, Freitas, E, Humphreys, I, Klenerman, P, Mallal, S, James, I, Roberts, S, Nolan, D, Lucas, M

Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. por Rauch, A, James, I, Pfafferott, K, Nolan, D, Klenerman, P, Cheng, W, Mollison, L, McCaughan, G, Shackel, N, Jeffrey, G, Baker, R, Freitas, E, Humphreys, I, Furrer, H, Günthard, H, Hirschel, B, Mallal, S, John, M, Lucas, M, Barnes, E, Gaudieri, S

Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. por Cosgrove, C, Ussher, J, Rauch, A, Gärtner, K, Kurioka, A, Hühn, M, Adelmann, K, Kang, Y, Fergusson, JR, Simmonds, P, Goulder, P, Hansen, T, Fox, J, Günthard, H, Khanna, N, Powrie, F, Steel, A, Gazzard, B, Phillips, R, Frater, J, Uhlig, H, Klenerman, P

CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells por Kurioka, A, Cosgrove, C, Simoni, Y, van Wilgenburg, B, Geremia, A, Björkander, S, Sverremark-Ekström, E, Thurnheer, C, Günthard, H, Khanna, N, Swiss HIV Cohort Study (50 Others), Oxford IBD Cohort Investigators et al., Walker, L, Arancibia-Cárcamo, C, Newell, E, Willberg, C, Klenerman, P